Pritesh P. Shah

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Revance Therapeutics, Inc. of its common stock for up to an aggregate amount of $125 million. Based…

Davis Polk advised the representatives of the several underwriters in connection with the $352 million follow-on offering of 11,000,000 shares of common stock of Jamf Holding Corp. sold by…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $307 million public offering of 4,150,000 shares of common stock…

Davis Polk advised Signify Health on its acquisition of PatientBlox. The acquisition accelerates Signify’s prospective provider payment capabilities for episodes of care, supporting the…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Finance of America Funding LLC of $350 million aggregate…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by MPH Acquisition Holdings LLC, a wholly owned subsidiary of MultiPlan…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of €450 million aggregate principal amount of senior notes due…

Davis Polk is advising Bansk Group in connection with its acquisition of Woodstream Corporation. Bansk Group is a private investment group focused on growth companies and has approximately …

Davis Polk is advising Cboe Global Markets on its acquisition of BIDS Trading, a registered broker-dealer and the operator of the BIDS Alternative Trading System. The transaction is…